Allosteric Modulation of Thrombin by Thrombomodulin: Insights from Logistic Regression and Statistical Analysis of Molecular Dynamics Simulations.
Research article published in ACS omega (2024)
Abstract
Thrombomodulin (TM), a transmembrane receptor integral to the anticoagulant pathway, governs thrombin's substrate specificity via interaction with thrombin's anion-binding exosite I. Despite its established role, the precise mechanisms underlying this regulatory function are yet to be fully unraveled. In this study, we deepen the understanding of these mechanisms through eight independent 1 μs all-atom simulations, analyzing thrombin both in its free form and when bound to TM fragments TM456 and TM56. Our investigations revealed distinct and significant conformational changes in thrombin mediated by the binding of TM56 and TM456. While TM56 predominantly influences motions within exosite I, TM456 orchestrates coordinated alterations across various loop regions, thereby unveiling a multifaceted modulatory role that extends beyond that of TM56. A highlight of our study is the identification of critical hydrogen bonds that undergo transformations during TM56 and TM456 binding, shedding light on the pivotal allosteric influence exerted by TM4 on thrombin's structural dynamics. This work offers a nuanced appreciation of TM's regulatory role in blood coagulation, paving the way for innovative approaches in the development of anticoagulant therapies and expanding the horizons in oncology therapeutics through a deeper understanding of molecular interactions in the coagulation pathway.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
Thrombomodulin (TM), a transmembrane receptor integral to the anticoagulant pathway, governs thrombin's substrate specificity via interaction with thrombin's anion-binding exosite I.
Why This Matters for Hirudotherapy
This computational study ran eight independent 1-microsecond all-atom molecular dynamics simulations of thrombin alone and bound to thrombomodulin fragments (TM456 and TM56), finding distinct conformational changes (TM56 acting chiefly on exosite I while TM456 coordinated changes across multiple loops) and identifying key hydrogen bonds that shift on binding, with the TM4 region exerting notable allosteric influence. Its relevance to hirudotherapy is mechanistic: thrombin and its anion-binding exosite I are the very targets engaged by the leech anticoagulant hirudin, so deeper structural understanding of how thrombin is allosterically regulated informs how leech-derived inhibitors work and how related anticoagulants might be designed. This is an in-silico simulation and statistical analysis, not laboratory or clinical work, and it does not study hirudin or hirudotherapy directly, so its contribution to ASH is conceptual context on thrombin biology rather than therapeutic evidence.
Citation
Allosteric Modulation of Thrombin by Thrombomodulin: Insights from Logistic Regression and Statistical Analysis of Molecular Dynamics Simulations.
Wu D et al. · ACS omega, 2024
Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026